The AI Regulatory Pivot: EU Delays and U.S. Vetting

EU officials delay high-risk compliance to 2027 as the U.S. weighs pharmaceutical-style vetting after the Mythos security breach. New state mandates and conflicting data policies in Asia further fragment global standards.